Cranbrook Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Cranbrook Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$130K	Hold	2,136	–	–	0.03%	143
2025 Q4	$115K	Hold	2,136	–	–	0.02%	153
2025 Q3	$96.3K	Buy	2,136 +390	+22%	+$18.2K	0.02%	166
2025 Q2	$80.8K	Sell	1,746 -77	-4%	-$3.78K	0.02%	174
2025 Q1	$111K	Sell	1,823 -88	-5%	-$5.13K	0.03%	141
2024 Q4	$108K	Buy	1,911 +2	+0.1%	+$112	0.03%	144
2024 Q3	$98.8K	Hold	1,909	–	–	0.02%	150
2024 Q2	$79.3K	Hold	1,909	–	–	0.02%	160
2024 Q1	$104K	Hold	1,909	–	–	0.03%	125
2023 Q4	$98K	Hold	1,909	–	–	0.03%	130
2023 Q3	$111K	Hold	1,909	–	–	0.03%	112
2023 Q2	$122K	Hold	1,909	–	–	0.03%	111
2023 Q1	$132K	Hold	1,909	–	–	0.04%	105
2022 Q4	$137K	Hold	1,909	–	–	0.04%	109
2022 Q3	$136K	Hold	1,909	–	–	0.04%	110
2022 Q2	$147K	Hold	1,909	–	–	0.04%	109
2022 Q1	$140K	Sell	1,909 -90	-5%	-$6.04K	0.03%	119
2021 Q4	$125K	Hold	1,999	–	–	0.03%	122
2021 Q3	$118K	Buy	1,999 +90	+5%	+$5.93K	0.03%	125
2021 Q2	$128K	Sell	1,909 -1,004	-34%	-$65.5K	0.03%	121
2021 Q1	$184K	Buy	2,913 +947	+48%	+$58.9K	0.04%	103
2020 Q4	$122K	Buy	1,966 +57	+3%	+$3.5K	0.03%	117
2020 Q3	$115K	Sell	1,909 -230	-11%	-$13.8K	0.03%	110
2020 Q2	$126K	Buy	2,139 +230	+12%	+$13.8K	0.04%	100
2020 Q1	$106K	Hold	1,909	–	–	0.04%	100
2019 Q4	$123K	Buy	1,909 +92	+5%	+$5.27K	0.03%	106
2019 Q3	$92K	Buy	1,817 +163	+10%	+$7.66K	0.03%	111
2019 Q2	$75K	Hold	1,654	–	–	0.02%	111
2019 Q1	$79K	Hold	1,654	–	–	0.02%	109
2018 Q4	$86K	Hold	1,654	–	–	0.03%	108
2018 Q3	$103K	Hold	1,654	–	–	0.04%	96
2018 Q2	$92K	Hold	1,654	–	–	0.04%	96
2018 Q1	$105K	Hold	1,654	–	–	0.04%	89
2017 Q4	$101K	Hold	1,654	–	–	0.04%	91
2017 Q3	$105K	Hold	1,654	–	–	0.04%	85
2017 Q2	$92K	Hold	1,654	–	–	0.04%	91
2017 Q1	$90K	Hold	1,654	–	–	0.04%	85
2016 Q4	$97K	Hold	1,654	–	–	0.05%	85
2016 Q3	$89K	Hold	1,654	–	–	0.04%	83
2016 Q2	$122K	Hold	1,654	–	–	0.06%	72
2016 Q1	$106K	Hold	1,654	–	–	0.06%	73
2015 Q4	$114K	Hold	1,654	–	–	0.06%	68
2015 Q3	$98K	Hold	1,654	–	–	0.06%	74
2015 Q2	$110K	Sell	1,654 -522	-24%	-$34.4K	0.06%	74
2015 Q1	$140K	Hold	2,176	–	–	0.08%	64
2014 Q4	$128K	Hold	2,176	–	–	0.08%	69
2014 Q3	$111K	Buy	2,176 +522	+32%	+$26.1K	0.07%	60
2014 Q2	$80K	Hold	1,654	–	–	0.05%	73
2014 Q1	$86K	Sell	1,654 -1,774	-52%	-$94.4K	0.06%	70
2013 Q4	$182K	Buy	+3,428	New	+$175K	0.12%	58

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cranbrook Wealth Management's BMY Position: Q1 2026 in Review

Cranbrook Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 2,136 shares worth $130K. The position accounts for 0.03% of the portfolio, ranked #143.

Cranbrook Wealth Management first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $184K in Q1 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Cranbrook Wealth Management held 2,136 shares of Bristol-Myers Squibb worth $130K as of Q1 2026.
Cranbrook Wealth Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.03% of Cranbrook Wealth Management's portfolio in Q1 2026, its #143 holding.
Cranbrook Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
Cranbrook Wealth Management's Bristol-Myers Squibb position peaked at $184K in Q1 2021.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cranbrook Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.